Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 1Metabolic Syndrome 1Inflammation 1Dyslipidemias 1

Interventions

Exercise 4Methods 2Educational Status 2Early Intervention, Educational 2Counseling 2semaglutide 1dexamethasone acetate 1dexamethasone 21-phosphate 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1auricularum 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Ultrasonic Waves 1Topiramate 1Tirzepatide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Robotic Surgical Procedures 1Resistance Training 1Qsymia 1Physical Examination 1Phentermine 1Parturition 1Naltrexone 1Liraglutide 1Interviews as Topic 1Glucagon-Like Peptide-1 Receptor 1Fluorescence Polarization Immunoassay 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Phentermine × Other × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡